	Reclassification of Noncanonical MET Splice-Site Variants Using RNA-Based Validation: A Practical Diagnostic Approach in Non-Small Cell Lung Cancer. Turk Patoloji Derg Mehta A, Saxena R, Pradhan S, Gopalan S, Panigrahi M. PMID: 42836578 [PubMed - as supplied by publisher]
	Genes, fuel, and fate in lung cancer. Biochem Soc Trans Scott JS, Lutz C, Prekovic S. PMID: 42836273 [PubMed - indexed for MEDLINE]
	Mitochondrial metabolic-transcriptional axis drives adaptive drug tolerance across major lung cancer subtypes. Front Genet Liu R, Wang X, Li Z, Mao W, Zhang W, Wang C, Tang Z. PMID: 42836261 [PubMed]
	Ever-smokers in Norway and lung cancer: median time from self-reported smoking debut to lung cancer diagnosis in 11 prospective population studies (CONOR). ERJ Open Res Nguyen OTD, Fotopoulos I, Tsamardinos I, Lagani V, Røe OD. PMID: 42835565 [PubMed]
	Renin-angiotensin system inhibitor use and survival outcomes in lung cancer: a systematic review and meta-analysis. Front Pharmacol Liao Y, Shen J, Liao Y, Lin Y, Zeng N. PMID: 42835318 [PubMed]
	Efficacy and Safety of First-Line Treatment Options for Oncogene Wild-Type Lung Adenocarcinoma With Liver Metastases. Cancer Med Li J, Ge Y, Liu Q, Wei X, Wang J, Wang X, Wang D, Liu J, Sun Y, Gao A. PMID: 42834503 [PubMed - indexed for MEDLINE]
	Epidemiology, exposure patterns and survival of malignant mesothelioma in Apulia, Italy (1993-2025): a population-based retrospective registry study. BMJ Open De Maria L, Cavone D, Delvecchio G, Serio G, Caputi A, Sole S, Aloia G, Lupariello V, Pierfelice A, Sindaco A, Schino V, Stufano A, Vimercati L. PMID: 42833719 [PubMed - indexed for MEDLINE]
	Lung Cancer Screening Beyond Smoking-Based Eligibility: Evidence, Limits, and Lessons From China. Chest He F, Xu Y, Tu B, Liu Y, Ye W, Zeng Y, Powell CA. PMID: 42833546 [PubMed - as supplied by publisher]
	Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial. Lancet Respir Med Soo RA, Popat S, Dafni U, de Langen AJ, Nadal E, Iranzo P, Früh M, Pérol M, Metro G, Sala MA, Cucurull Salamero M, Cerciello F, Addeo A, Dómine M, Oulkhouir Y, Cloarec N, López Castro R, Froesch P, Roschitzki-Voser H, Ruepp B, Gasca-Ruchti A, Dellaporta T, Peters S, Stahel RA, ETOP AMAZE-lung collaborators. PMID: 42833236 [PubMed - as supplied by publisher]
	Discordance between physician dose decisions and Cancer and Aging Research Group-defined vulnerability in older adults with lung cancer: A prospective observational study. J Geriatr Oncol Watanabe H, Hirai K, Nakauchi K, Ishii R, Tateishi K, Sonehara K, Araki T, Naito T. PMID: 42833070 [PubMed - as supplied by publisher]
	PLAG1-rearranged pulmonary metastases from pleomorphic adenoma-spectrum salivary gland neoplasms: A clinicopathologic study of metastasizing pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Pathol Res Pract Zhang M, Xu C, Gao X, Du Q, Zheng X, Han J, Chen K, Liu E, Li S. PMID: 42832992 [PubMed - as supplied by publisher]
	EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification. PLoS One Jamil MA, Awan MDA, Bukhari F, Missen MMS, Kajla NI. PMID: 42832554 [PubMed - indexed for MEDLINE]
	Harmonizing the National Lung Screening Trial: Kernel resolution and field of view compensation. PLoS One Krishnan AR, Kim ME, Gao C, Rudravaram G, Schwartz T, Hucke ATS, Remedios LW, Li TZ, Xu K, Sandler KL, Martinez YF, Antic S, Maldonado F, Zuo L, Landman BA. PMID: 42832530 [PubMed - indexed for MEDLINE]
	The Role of Cancer-Related Fatalistic Beliefs and Perceived Information Ambiguity in Lung Cancer Screening Uptake. Clin J Oncol Nurs Zaidi M, Sarkar S, Poghosyan H. PMID: 42832316 [PubMed - indexed for MEDLINE]
	Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial. JAMA Hart JL, Vachani A, Neslund-Dudas CM, Gould MK, Facktor MA, Blady S, Bayes BA, Sheu D, Madden VL, Ferrante EB, Patel N, Tian J, Whitman C, Creekmur B, Kohn R, Simoff MJ, Volpp KG, Small D, Scott ME, Holm AL, Stephens Shields AJ, Halpern SD. PMID: 42832220 [PubMed - as supplied by publisher]
	Clinical Characteristics and Outcomes of Patients with Lymphangioleiomyomatosis. Lung Yoon HY, Park SW, Park JS, Kwon BS, Jo YS, Jegal Y, Oh JH, Park JH, Lee JH, Yoo H, Kim BG, Kim TH, Park JK, Woo A, Song JW. PMID: 42832099 [PubMed - indexed for MEDLINE]
	Radiomics machine learning models for lung cancer early diagnosis in heterogenous multicentre chest CT data: LIBRA study results. Eur Radiol Exp Hunter B, Ratnakumar P, Tong D, Senthivel N, Bhamani A, Coe A, Bloch S, Kemp SV, Doran S, Navani N, Nair A, Ratoff J, Wells CE, Garner J, Nicolson A, Bunce C, Blackledge M, Devaraj A, Aboagye EO, Lee RW. PMID: 42831983 [PubMed - indexed for MEDLINE]
	Predictive modeling of lung cancer subtype with integration of clinical and thoracic imaging features to guide early brain metastasis management. J Neurooncol Park J, Buclez P, Lubisich J, Hanubal K, Inda A, Hui C, Harris J, Simon A. PMID: 42831966 [PubMed - indexed for MEDLINE]
	[Therapeutic success of sacituzumab govitecan in a patient with a primary diagnosis of triple-cancer: locally advanced triple-negative breast cancer, colon cancer and lung cancer.]. Recenti Prog Med Pernice G, Spada M. PMID: 42831722 [PubMed - indexed for MEDLINE]
	Correlation of the Diagnostic Accuracy of Dual Energy Computed Tomography and Positron Emission Tomography/Computed Tomography in Mediastinal Lymph Node Staging in Lung Cancer: A Systematic Review. Cureus Adebayo D, England A, McEntee M, Ryan DJ, Maher M. PMID: 42831153 [PubMed]

Articles 1 - 20 / 162520

Page 1 of 8126



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy